Smith Julie
Insider CIK 1557928 · RPTP President and CEO-Designate, Director · STOK Director · BOLD Director · EXEL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2026-06-03 | 2026-06-05 | 17,786 | — | $0 | 17,786 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2026-05-27 | 2026-05-29 | 8,367 | — | $0 | 28,957 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2026-02-18 | 2026-02-19 | 44,087 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2026-02-18 | 2026-02-19 | 20,030 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2026-02-18 | 2026-02-19 | 20,030 | $44.30 | $887.3K | 20,590 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2026-02-18 | 2026-02-19 | 44,087 | $19.39 | $854.8K | 64,677 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2026-02-18 | 2026-02-19 | 44,087 | $44.50 | $1.96M | 20,590 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2026-02-18 | 2026-02-19 | 20,030 | $21.69 | $434.5K | 40,620 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2026-02-17 | 2026-02-19 | 42,422 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2026-02-17 | 2026-02-19 | 42,422 | $18.19 | $771.7K | 63,012 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2026-02-17 | 2026-02-19 | 42,422 | $43.33 | $1.84M | 20,590 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2025-06-03 | 2025-06-04 | 29,747 | — | $0 | 29,747 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2025-05-29 | 2025-05-30 | 9,812 | — | $0 | 20,590 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2025-02-28 | 2025-02-28 | 19,294 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2025-02-28 | 2025-02-28 | 19,294 | $37.62 | $725.8K | 10,778 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2025-02-28 | 2025-02-28 | 19,294 | $19.77 | $381.4K | 30,072 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2025-02-27 | 2025-02-28 | 23,347 | — | $0 | 19,294 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2025-02-27 | 2025-02-28 | 31,167 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2025-02-27 | 2025-02-28 | 23,347 | $19.77 | $461.6K | 65,292 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2025-02-27 | 2025-02-28 | 31,167 | $20.50 | $638.9K | 41,945 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2025-02-27 | 2025-02-28 | 54,514 | $38.13 | $2.08M | 10,778 | SEC↗ |
| EXEL EXELIXIS, INC. | J Other | 2024-08-13 | 2024-08-15 | 4,682 | — | $0 | 10,778 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 7,639 | — | $0 | 7,639 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2024-05-31 | 2024-06-04 | 20,030 | — | $0 | 20,030 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2024-05-31 | 2024-06-04 | 10,015 | — | $0 | 15,460 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2024-05-21 | 2024-05-23 | 27,280 | $21.12 | $576.2K | 5,445 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 19,441 | — | $0 | 19,441 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2023-06-01 | 2023-06-02 | 44,087 | — | $0 | 44,087 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2022-06-07 | 2022-06-08 | 21,000 | — | $0 | 21,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2022-05-26 | 2022-05-27 | 42,422 | — | $0 | 42,422 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2021-06-08 | 2021-06-25 | 11,650 | — | $0 | 11,650 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2021-05-27 | 2021-05-28 | 16,424 | — | $0 | 32,725 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 29,555 | — | $0 | 29,555 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2020-05-21 | 2020-05-22 | 15,538 | — | $0 | 16,301 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 10,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 16,200 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 9,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 18,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2019-05-23 | 2019-05-24 | 42,641 | — | $0 | 42,641 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2019-02-06 | 2019-02-08 | 16,200 | — | $0 | 16,200 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2018-06-08 | 2018-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2018-05-24 | 2018-05-24 | 31,167 | — | $0 | 31,167 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2017-10-08 | 2017-10-10 | 9,000 | — | $0 | 9,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2017-05-25 | 2017-05-26 | 23,491 | — | $0 | 23,491 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2017-02-23 | 2017-02-24 | 16,620 | — | $0 | 16,620 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2017-01-01 | 2017-01-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | D To issuer deriv | 2016-10-25 | 2016-10-26 | 152,050 | — | $0 | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | D To issuer deriv | 2016-10-25 | 2016-10-26 | 175,000 | — | $0 | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | D To issuer deriv | 2016-10-25 | 2016-10-26 | 240,595 | — | $0 | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | D To issuer | 2016-10-25 | 2016-10-26 | 64,179 | $9.00 | $577.6K | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | U Tender | 2016-10-24 | 2016-10-26 | 45,759 | $9.00 | $411.8K | 64,179 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2016-09-22 | 2016-09-26 | 26,000 | — | $0 | 26,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2016-09-22 | 2016-09-26 | 763 | — | $0 | 763 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award deriv | 2016-02-09 | 2016-02-11 | 240,595 | — | $0 | 240,595 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award | 2016-02-09 | 2016-02-11 | 64,179 | — | $0 | 102,129 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award deriv | 2015-01-15 | 2015-01-20 | 350,000 | — | $0 | 350,000 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2014-12-03 | 2014-12-05 | 37,950 | — | $0 | 152,050 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2014-12-03 | 2014-12-05 | 37,950 | $5.27 | $200.0K | 37,950 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award deriv | 2014-07-29 | 2014-07-31 | 175,000 | — | $0 | 175,000 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award deriv | 2014-02-07 | 2014-02-11 | 107,065 | — | $0 | 107,065 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award deriv | 2012-09-10 | 2012-09-12 | 190,000 | — | $0 | 190,000 | SEC↗ |